The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000329.3(RPE65):c.432C>T (p.Tyr144=)

CA226551

98869 (ClinVar)

Gene: RPE65
Condition: RPE65-related recessive retinopathy
Inheritance Mode: Autosomal recessive inheritance
UUID: 8e911e71-3693-4daf-b9ae-6cb15e45c36a
Approved on: 2024-04-22
Published on: 2024-04-22

HGVS expressions

NM_000329.3:c.432C>T
NM_000329.3(RPE65):c.432C>T (p.Tyr144=)
NC_000001.11:g.68444594G>A
CM000663.2:g.68444594G>A
NC_000001.10:g.68910277G>A
CM000663.1:g.68910277G>A
NC_000001.9:g.68682865G>A
NG_008472.1:g.10366C>T
NG_008472.2:g.10366C>T
ENST00000262340.6:c.432C>T
ENST00000262340.5:c.432C>T
NM_000329.2:c.432C>T

Benign

Met criteria codes 1
BA1
Not Met criteria codes 2
BP7 BP4

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Leber Congenital Amaurosis/early onset Retinal Dystrophy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RPE65 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP
NM_000329.3(RPE65):c.432C>T (p.Tyr144=) is a synonymous variant located in exon 5. This variant is present in gnomAD v.4.0.0 at a GrpMax allele frequency of 0.01115, with 852 alleles/75,028 total alleles in the African/African-American population, which is higher than the ClinGen LCA / eoRD VCEP BA1 threshold of >0.008 (BA1). Additionally, there are 5 homozygotes in this population in gnomAD. The splicing impact predictor SpliceAI gives a delta score of 0.15 for acceptor gain, which is above the ClinGen LCA / eoRD VCEP threshold of <0.1, so BP4 and BP7 are not met. In summary, this variant meets the criteria to be classified as benign for RPE65-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA / eoRD VCEP: BA1. (VCEP specifications version 1.0.0; date of approval 09/21/2023).
Met criteria codes
BA1
This variant is present in gnomAD v.4.0.0 at a GrpMax allele frequency of 0.01115, with 852 alleles/75,028 total alleles in the African/African American population, which is higher than the ClinGen LCA/eoRD VCEP BA1 threshold of >0.008. Additionally, there are 5 homozygotes in this population in gnomAD (BA1).
Not Met criteria codes
BP7
The splicing impact predictor SpliceAI gives a delta score of 0.15 at 78bp, which is above the ClinGen LCA / eoRD VCEP threshold of <0.1 (BP7 not met).
BP4
There is no REVEL data for this variant. The splicing impact predictor SpliceAI gives a delta score of 0.15 at 78bp, which is above the ClinGen LCA/eoRD VCEP threshold of <0.1 (BP4 not met).
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.